Journal of Korean Medicine for Obesity Research (한방비만학회지)

The Society of Korean Medicine for obesity Research (한방비만학회)
권호 표지
DOI QR코드

DOI QR Code

Review on Predictors of Weight Loss in Moderate to Severe Obesity Treatment

중고도 비만 치료에 있어서 체중감량에 영향을 주는 인자들에 대한 고찰

  • Received : 2023.09.27
  • Accepted : 2023.11.29
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study was to review predictive factors associated with weight loss in moderate to severe obesity treatment. The direction of the treatment for moderate to severe obesity will be suggested in consideration of various factors. Methods: Authors searched the articles published from 2018 to 2023 in three international databases (PubMed, Embase and the Cochrane Central Register of Controlled Trials) and two domestic databases (Research Information Sharing Service, Korean studies Information Service System). Studies including treatment with moderate to severe obese patients were selected. Results: A total of 43 studies were included. The main factors of weight loss were unchangeable predictors such as low initial degree of obesity, younger age, non-diabetes and high resting energy expenditure with changeable predictors such as increase in protein, physical activity, self-efficacy, initial weight loss and attendance of the treatment. Conclusions: Our review results suggest that based on the characteristics of moderate to severe obese patients, predictors of weight loss can be used to determine treatment and prognosis in various aspects.

Keywords

References

  1. Bray GA, Bouchard C. Handbook of obesity: epidemiology, etiology, and physiopathology. 3rd ed. CRC Press. 2014 : 1-736.
  2. Korean Society for the Study of Obesity. 2018 Obesity practice guideline [Internet]. 2018 [cited 2020 May 19]. https://www.medric.or.kr/Uploads/BLibrary/file180614.pdf
  3. Yang YS, Han BD, Han K, Jung JH, Son JW; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity Fact Sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022 ; 31(2) : 169-77. https://doi.org/10.7570/jomes22024
  4. Ricci MA, De Vuono S, Scavizzi M, Gentili A, Lupattelli G. Facing morbid obesity: how to approach it. Angiology. 2016 ; 67(4) : 391-7. https://doi.org/10.1177/0003319715595735
  5. Kim YS. Principles of obesity treatment and weight loss treatment. Korean J Med. 1997 ; 53(Suppl 2) : S763-9.
  6. Lee CM, Kim JH. Surgical treatment of morbid obesity. Korean J Helicobacter Up Gastrointest Res. 2017 ; 17(2) : 72-8. https://doi.org/10.7704/kjhugr.2017.17.2.72
  7. Bray GA. Pathophysiology of obesity. Am J Clin Nutr. 1992 ; 55(2 Suppl) : 488S-494S. https://doi.org/10.1093/ajcn/55.2.488s
  8. Consultation WHO. Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser. 2000 ; 894 : 1-253.
  9. Huh Y, Nam GE. Overcoming increasing morbid obesity in Korea. J Obes Metab Syndr. 2021 ; 30(2) : 77-80. https://doi.org/10.7570/jomes21052
  10. Keating C, Backholer K, Gearon E, Stevenson C, Swinburn B, Moodie M, et al. Prevalence of class-I, class-II and class-III obesity in Australian adults between 1995 and 2011-12. Obes Res Clin Pract. 2015 ; 9(6) : 553-62. https://doi.org/10.1016/j.orcp.2015.02.004
  11. Nam SH, Kim SY, Lim YW, Park YB. Review on predictors of weight loss in obesity treatment. J Korean Med Obes Res. 2018 ; 18(2) : 115-27. https://doi.org/10.15429/jkomor.2018.18.2.115
  12. Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020 ; 192(31) : E875-91. https://doi.org/10.1503/cmaj.191707
  13. Ambrosini GL, Solis-Trapala I, Ahern AL, Fuller NR, Holzapfel C, Hauner H, et al. Greater improvements in diet quality among overweight participants following a group-based commercial weight loss programme than those receiving support to lose weight in primary care. Nutr J. 2018 ; 17(1) : 64.
  14. Funk LM, Grubber JM, McVay MA, Olsen MK, Yancy WS, Voils CI. Patient predictors of weight loss following a behavioral weight management intervention among US Veterans with severe obesity. Eat Weight Disord. 2018 ; 23(5) : 587-95. https://doi.org/10.1007/s40519-017-0425-6
  15. Raman J, Hay P, Tchanturia K, Smith E. A randomised controlled trial of manualized cognitive remediation therapy in adult obesity. Appetite. 2018 ; 123 : 269-79. https://doi.org/10.1016/j.appet.2017.12.023
  16. Sasdelli AS, Petroni ML, Delli Paoli A, Collini G, Calugi S, Dalle Grave R, et al. Expected benefits and motivation to weight loss in relation to treatment outcomes in group-based cognitive-behavior therapy of obesity. Eat Weight Disord. 2018 ; 23(2) : 205-14. https://doi.org/10.1007/s40519-017-0475-9
  17. Tronieri JS, Wadden TA, Chao AM, Pearl RL, Alamuddin N, Berkowitz RI. Early weight loss in behavioral treatment predicts later rate of weight loss and response to pharmacotherapy. Ann Behav Med. 2019 ; 53(3) : 290-5. https://doi.org/10.1093/abm/kay036
  18. Bjorkman S, Wallengren O, Laurenius A, Eliasson B, Larsson I. Nocturnal eating but not binge eating disorder is related to less 12 months' weight loss in men and women with severe obesity: a retrospective cohort study. Clin Obes. 2020 ; 10(6) : e12408.
  19. Frie K, Hartmann-Boyce J, Jebb SA, Aveyard P. Effectiveness of a self-regulation intervention for weight loss: a randomized controlled trial. Br J Health Psychol. 2020 ; 25(3) : 652-76. https://doi.org/10.1111/bjhp.12436
  20. Bjorkman S, Wallengren O, Laurenius A, Eliasson B, Larsson I. Locus of control and self-efficacy in relation to 12-month weight change after non-surgical weight loss treatment in adults with severe obesity - a clinical cohort study. Obes Med. 2022 ; 32 : 100409.
  21. Kempf K, Rohling M, Banzer W, Braumann KM, Halle M, Schaller N, et al. Early and strong leptin reduction is predictive for long-term weight loss during high-protein, low-glycaemic meal replacement-a subanalysis of the randomised-controlled ACOORH trial. Nutrients. 2022 ; 14(12) : 2537.
  22. Chao AM, Zhou Y, Erus G, Davatzikos C, Cardel MI, Foster GD, et al. A randomized controlled trial examining the effects of behavioral weight loss treatment on hippocampal volume and neurocognition. Physiol Behav. 2023 ; 267 : 114228.
  23. Fujioka K, Malhotra M, Perdomo C, Apovian CM. Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM-DM studies. Obes Sci Pract. 2019 ; 5(2) : 120-9. https://doi.org/10.1002/osp4.335
  24. Wharton S, Liu A, Pakseresht A, Nortoft E, Haase CL, Mancini J, et al. Real-world clinical effectiveness of liraglutide 3.0 mg for weight management in Canada. Obesity (Silver Spring). 2019 ; 27(6) : 917-24. https://doi.org/10.1002/oby.22462
  25. Maccora C, Ciuoli C, Goracci A, Benenati N, Formichi C, Pilli T, et al. One month weight loss predicts the efficacy of liraglutide in obese patients: data from a single center. Endocr Pract. 2020 ; 26(2) : 235-40. https://doi.org/10.4158/EP-2019-0169
  26. Tronieri JS, Wadden TA, Walsh O, Berkowitz RI, Alamuddin N, Chao AM. Measures of adherence as predictors of early and total weight loss with intensive behavioral therapy for obesity combined with liraglutide 3.0 m g. B ehav R es T her. 2 020 ; 1 31 : 1 03639.
  27. Tchang BG, Aras M, Wu A, Aronne LJ, Shukla AP. Long-term weight loss maintenance with obesity pharmacotherapy: a retrospective cohort study. Obes Sci Pract. 2021 ; 8(3) : 320-7. https://doi.org/10.1002/osp4.575
  28. Vargas EJ, Pesta CM, Bali A, Ibegbu E, Bazerbachi F, Moore RL, et al. Single fluid-filled intragastric balloon safe and effective for inducing weight loss in a real-world population. Clin Gastroenterol Hepatol. 2018 ; 16(7) : 1073-80.e1. https://doi.org/10.1016/j.cgh.2018.01.046
  29. Jambhekar A, Maselli A, Robinson S, Kabata K, Gorecki P. Demographics and socioeconomic status as predictors of weight loss after laparoscopic sleeve gastrectomy: a prospective cohort study. Int J Surg. 2018 ; 54(Pt A) : 163-9. https://doi.org/10.1016/j.ijsu.2018.04.025
  30. Nguyen NT, Kim E, Vu S, Phelan M. Ten-year outcomes of a prospective randomized trial of laparoscopic gastric bypass versus laparoscopic gastric banding. Ann Surg. 2018 : 268(1) : 106-13. https://doi.org/10.1097/SLA.0000000000002348
  31. Bettencourt-Silva R, Neves JS, Pedro J, Guerreiro V, Ferreira MJ, Salazar D, et al. Comparative effectiveness of different bariatric procedures in super morbid obesity. Obes Surg. 2019 ; 29(1) : 281-91. https://doi.org/10.1007/s11695-018-3519-y
  32. Erdogdu UE, Cayci HM, Tardu A, Demirci H, Kisakol G, Guclu M. Health literacy and weight loss after bariatric surgery. Obes Surg. 2019 ; 29(12) : 3948-53. https://doi.org/10.1007/s11695-019-04060-7
  33. Flolo TN, Tell GS, Kolotkin RL, Aasprang A, Norekval TM, Vage V, et al. Eating self-efficacy as predictor of long-term weight loss and obesity-specific quality of life after sleeve gastrectomy: a prospective cohort study. Surg Obes Relat Dis. 2019 ; 15(2) : 161-7. https://doi.org/10.1016/j.soard.2018.12.011
  34. Itlaybah A, Elbanna H, Emile S, Thabet W, Elkashef W, Abdelsalam N, et al. Correlation between the number of ghrelin-secreting cells in the gastric fundus and excess weight loss after sleeve gastrectomy. Obes Surg. 2019 ; 29(1) : 76-83. https://doi.org/10.1007/s11695-018-3498-z
  35. Mazzini GS, Khoraki J, Browning MG, Pessoa BM, Wolfe LG, Campos GM. Population diversity challenge the external validity of the European randomized controlled trials comparing laparoscopic gastric bypass and sleeve gastrectomy. Obes Surg. 2020 ; 30(3) : 992-1000. https://doi.org/10.1007/s11695-019-04247-y
  36. Pinto SL, Juvanhol LL, Bressan J. Increase in protein intake a fter 3 m onths of RYGB i s an independent p redictor for the remission of obesity in the first year of surgery. Obes Surg. 2019 ; 29(12) : 3780-5. https://doi.org/10.1007/s11695-019-04124-8
  37. Aliakbarian H, Bhutta HY, Heshmati K, Unes Kunju S, Sheu EG, Tavakkoli A. Pre-operative predictors of weight loss and weight regain following Roux-en-Y gastric bypass surgery: a prospective human study. Obes Surg. 2020 ; 30(12) : 4852-9. https://doi.org/10.1007/s11695-020-04877-7
  38. Ansar H, Zamaninour N, Pazouki A, Kabir A. Weight loss after one anastomosis gastric bypass-mini gastric bypass (OAGB-MGB): patient-related perioperative predictive factors. Obes Surg. 2020 ; 30(4) : 1316-23. https://doi.org/10.1007/s11695-019-04270-z
  39. Farup PG. Are the results of a combined behavioural and surgical treatment of morbid obesity satisfactory and predictable? Nutrients. 2020 ; 12(7) : 1997.
  40. Li K, Zheng L, Guo J, Shi W, Zhao F, Yang C, et al. Increased resting energy expenditure/body weight and decreased respiratory quotient correlate with satisfactory weight loss after sleeve gastrectomy: a 6-month follow-up. Obes Surg. 2020 ; 30(4) : 1410-6. https://doi.org/10.1007/s11695-019-04308-2
  41. Panella C, Busto M, Gonzalez A, Serra C, Goday A, Grande L, et al. Correlation of gastric volume and weight loss 5 years following sleeve gastrectomy. Obes Surg. 2020 ; 30(6) : 2199-205. https://doi.org/10.1007/s11695-020-04445-z
  42. Rheinwalt KP, Drebber U, Schierwagen R, Klein S, Neumann UP, Ulmer TF, et al. Baseline presence of NAFLD predicts weight loss after gastric bypass surgery for morbid obesity. J Clin Med. 2020 ; 9(11) : 3430.
  43. Smith KR, Papantoni A, Veldhuizen MG, Kamath V, Harris C, Moran TH, et al. Taste-related reward is associated with weight loss following bariatric surgery. J Clin Invest. 2020 ; 130(8) : 4370-81. https://doi.org/10.1172/JCI137772
  44. Ben-Porat T, Mashin L, Kaluti D, Goldenshluger A, Shufanieh J, Khalaileh A, et al. Weight loss outcomes and lifestyle patterns following sleeve gastrectomy: an 8-year retrospective study of 212 patients. Obes Surg. 2021 ; 31(11) : 4836-45. https://doi.org/10.1007/s11695-021-05650-0
  45. Casajoana A, Guerrero-Perez F, Garcia Ruiz de Gordejuela A, Admella V, Sorribas M, Vidal-Alabro A, et al. Role of gastrointestinal hormones as a predictive factor for long-term diabetes remission: randomized trial comparing metabolic gastric bypass, sleeve gastrectomy, and greater curvature plication. Obes Surg. 2021 ; 31(4) : 1733-44. https://doi.org/10.1007/s11695-020-05192-x
  46. El Moussaoui I, Van Vyve E, Johanet H, Dabrowski A, Piquard A, Delaunay T, et al. Laparoscopic sleeve gastrectomy for morbid obesity in a Belgian-French prospective multicenter study: outcomes and predictors weight loss failure. Acta Chir Belg. 2021 ; 121(6) : 413-9. https://doi.org/10.1080/00015458.2020.1841485
  47. Felske AN, Williamson TM, Scurrey SRM, Telfer JA, Campbell TS, Rash JA. The influence of weight-related self-esteem and symptoms of depression on shape and weight concerns and weight-loss 12 months after bariatric surgery. Obes Surg. 2021 ; 31(3) : 1062-72. https://doi.org/10.1007/s11695-020-05097-9
  48. Fidilio E, Comas M, Giribes M, Cardenas G, Vilallonga R, Palma F, et al. Evaluation of resting energy expenditure in subjects with severe obesity and its evolution after bariatric surgery. Obes Surg. 2021 ; 31(10) : 4347-55. https://doi.org/10.1007/s11695-021-05578-5
  49. Huang X, Li G, Xu B, Zhang J, Wang X, Cheng X, et al. Lower baseline serum triglyceride levels are associated with higher decrease in body mass index after laparoscopy sleeve gastrectomy among obese patients. Front Endocrinol (Lausanne). 2021 ; 12 : 633856.
  50. Bahadori E, Esfehani AJ, Bahrami LS, Shadmand Foumani Moghadam MR, Jangjoo A, Nematy M, et al. Identifying the predictors of short term weight loss failure after Roux-En-Y gastric bypass. Int J Clin Pract. 2022 ; 2022 : 2685292.
  51. Guo L, Luo W, Tan T, Gong F, Liu X, Rao S, et al. Early-phase insulin hypersecretion associated with weight loss outcome after LSG: a prospective cohort study in Asian patients with BMI ≥28 kg/m2. Surg Obes Relat Dis. 2022 ; 18(10) : 1209-17. https://doi.org/10.1016/j.soard.2022.05.013
  52. Mantziari S, Thomopoulos T, Abboretti F, Gaspar-Figueiredo S, Dayer A, Demartines N, et al. Long-term weight loss and metabolic benefit from Roux-en-Y gastric bypass in patients with superobesity. BJS Open. 2022 ; 6(6) : zrac145.
  53. Miranda-Penarroya G, Zeron-Rugerio MF, Vallejo-Gracia M, Sorio-Fuentes R, Saenger-Ruiz F, Izquierdo-Pulido M. Adherence to healthy lifestyle habits is a determinant of the effectiveness of weight loss among patients undergoing endoscopic bariatric therapies. Nutrients. 2022 ; 14(11) : 2261.
  54. Tan EY, L ee PC, Tham KW, Ganguly S, Lim CH, L iu JCJ. Examining spousal and family support as predictors of long-term weight loss and remission of type 2 diabetes following bariatric surgery in Singapore: a retrospective cohort study. BMJ Open. 2023 ; 13(5) : e068810. https://doi.org/10.1136/bmjopen-2022-068810
  55. Park H, H uh Y, Kim S, Yoo MW, Ko C S, P ark HS. Longitudinal changes of body weight according to sex.age and metabolic parameters in Korean morbid obese patients after sleeve gastrectomy: 12-month retrospective cohort study. Korean J Fam Pract. 2022 ; 12(3) : 185-92. https://doi.org/10.21215/kjfp.2022.12.3.185
  56. Jang IY, Yim JH, Park JS, Kim JS, Kim TH, Jang IY, et al. Korean medicine with self-monitoring for weight control and factors associated with weight loss: a retrospective observational study. J Korean Med. 2022 ; 43(1) : 87-98. https://doi.org/10.13048/jkm.22008
  57. Kim S, Han K, Kwon O, Lee W, Yoon C, Lee JH. Effect of Korean medicine treatment including Korean medicine counselling on weight loss in patients with morbid obesity: a retrospective chart review. J Korean Med Obes Res. 2021 ; 21(1) : 22-31. https://doi.org/10.15429/jkomor.2021.21.1.22
  58. Pfefferkorn U, Hort S, Beluli M, La Vista M, Zuger T. Weight loss after bariatric surgery in different age groups. Obes Surg. 2023 ; 33(4) : 1154-9. https://doi.org/10.1007/s11695-023-06488-4